Indirect Calorimeter Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The indirect calorimeter market is anticipated to register a CAGR of about 4.1%, over the forecast period. Certain factors driving the market's growth include technological advancements in the indirect calorimeter and the rising burden of obesity. Obesity has significantly increased worldwide, especially over the past few decades. According to 2018 statistics by the World Health Organization (WHO), the global obesity rate has nearly tripled since 1975. As per WHO 2018 report on “Obesity and Overweight”, in 2016, more than 1.9 billion adults (18 years and older) were overweight, of which, over 650 million were obese. This accounts for nearly 39% of adults who were overweight and 13% who were obese, worldwide. Obesity has been linked to causing many other dreadful diseases and disorders, like cardiovascular diseases, mainly heart disease and stroke; diabetes; musculoskeletal disorders, especially osteoarthritis, a degenerative disease of the joints; and cancer, including endometrial, breast, ovarian, prostate, liver, gallbladder, kidney, and colon.

Medical devices, such as indirect calorimeters, are becoming more important in the healthcare sector. The major issue faced by companies in developing and producing such medical devices is to be updated on the regulatory requirements and implement them in the process. Currently, different countries follow different regulatory requirements for approval of medical devices. This factor is expected to hinder the market's growth to a certain extent.

Key Market Trends

Hospital Holds Significant Share in the Global Indirect Calorimeter Market

In hospitals, indirect calorimetry measures the gases in the air one exhales as a way to determine how many calories one’s body burns at rest. Indirect calorimetry (IC) is the gold standard for evaluating calorie needs. Mostly, IC is used in all the patients of a tertiary care hospital, with more emphasis on the patient with the obesity-related records. Use of IC can be used to target nutritional goals, as both protein and AC/REE (administered calories to resting energy expenditure ratio) show trend toward better survival, at the cost of increased length of stay. Parenteral nutrition showed a protective trend, contrary to current conceptions. As a significant player in this field with products in calorimetry and artificial environment control rooms, Fuji Medical Science is intensifying R&D collaboration in East Asia to lead the way in the treatment of aging and lifestyle diseases. With the presence of major medical devices companies targeting hospitals as a primary end-user, it's expected to show more share in the market, over the forecast period.

North America Dominates the Global Indirect Calorimeter Market

Overall, North America is expected to dominate the market, due to the increasing number of obese populations across the region. Another driving factor is the availability of better healthcare infrastructure in the region and the rising awareness about facilities available for obese people. In the North American region, the United States holds the largest market share. The number of people suffering from obesity in America has been increasing. In 2018, the Centers for Disease Control and Prevention (CDC) estimated that around 39.8% of American adults are obese. This obesity is often the primary factor for many diseases and patients approaching hospitals for treatment with that record. This leads to the growing usage of indirect calorimeters for treatments associated with these patients.

Competitive Landscape

The indirect calorimeter market is competitive and consists of a few major players. Recently, a forerunner in the field of calorimetry with world-leading products in calorimetry and artificial environment control rooms, Fuji Medical Science has intensified R&D collaboration in East Asia to break new ground in the treatment of aging and lifestyle diseases. Companies, like Cosmed srl, KORR Medical Technologies, Maastricht Instruments BV, MGC Diagnostics, Microlife USA, Pacific Medico Co.Ltd, Parvo Medics, and Vyaire Medical, among others, hold a substantial share in the market.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support